ES2068216T3 - Compuestos de tienotriazolodiazepina y usos farmaceuticos de los mismos. - Google Patents

Compuestos de tienotriazolodiazepina y usos farmaceuticos de los mismos.

Info

Publication number
ES2068216T3
ES2068216T3 ES89108752T ES89108752T ES2068216T3 ES 2068216 T3 ES2068216 T3 ES 2068216T3 ES 89108752 T ES89108752 T ES 89108752T ES 89108752 T ES89108752 T ES 89108752T ES 2068216 T3 ES2068216 T3 ES 2068216T3
Authority
ES
Spain
Prior art keywords
tienotriazolodiazepine
compounds
pharmaceutical uses
paf
symbol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89108752T
Other languages
English (en)
Inventor
Minoru Moriwaki
Youichi Akiyama
Ken-Ichi Demizu
Hiroshi Mikashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Application granted granted Critical
Publication of ES2068216T3 publication Critical patent/ES2068216T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

UN COMPUESTOS DE TIENOTRIAZOLODIAZEPINA DE FORMULA(I), DONDE CADA SIMBOLO ES COMO SE DEFINE EN LA ESPECIFICACION, O UNA SAL DE ADICION ACIDA FARMACEUTICAMENTE ACEPTABLE Y SUS APLICACIONES FARMACEUTICAS. DICHOS COMPUESTOS MUESTRANA ACTIVIDAD ANTAGONISTA PAF Y SON UTILES PARA LA PREVENCION O TRATAMIENTO DE VARIAS ENFERMEDADES INDUCIDAS POR PAF.
ES89108752T 1988-05-17 1989-05-16 Compuestos de tienotriazolodiazepina y usos farmaceuticos de los mismos. Expired - Lifetime ES2068216T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11971388 1988-05-17

Publications (1)

Publication Number Publication Date
ES2068216T3 true ES2068216T3 (es) 1995-04-16

Family

ID=14768268

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89108752T Expired - Lifetime ES2068216T3 (es) 1988-05-17 1989-05-16 Compuestos de tienotriazolodiazepina y usos farmaceuticos de los mismos.

Country Status (8)

Country Link
US (1) US4910194A (es)
EP (1) EP0342587B1 (es)
JP (1) JPH0641471B2 (es)
KR (1) KR910007978B1 (es)
AT (1) ATE114154T1 (es)
CA (1) CA1322367C (es)
DE (1) DE68919378T2 (es)
ES (1) ES2068216T3 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
FR2659332B1 (fr) * 1990-03-08 1994-04-29 Adit Et Cie Nouvelles pyrrolo [1,2-a] thieno [3,2-f] diazepines [1,4], leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE4010528A1 (de) * 1990-04-02 1991-10-17 Boehringer Ingelheim Kg Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
US5302590A (en) * 1992-12-18 1994-04-12 Hoffmann-La Roche Inc. Compounds useful as dual antagonists of platelet activating factor and leukotriene D4
CA2294139A1 (en) 1997-06-25 1998-12-30 Nikken Chemicals Co., Ltd. Triazolo-1,4-diazepine compounds and medicinal composition containing the same
US6252756B1 (en) * 1998-09-18 2001-06-26 Illinois Tool Works Inc. Low voltage modular room ionization system
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2705039B1 (en) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9328117B2 (en) 2011-06-17 2016-05-03 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9624244B2 (en) 2012-06-06 2017-04-18 Constellation Pharmaceuticals, Inc. Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
PL3157928T3 (pl) 2014-06-20 2019-07-31 Constellation Pharmaceuticals, Inc. Krystaliczne postacie 2-((4S)-6-(4-chlorofenylo)-1-metylo-4H-benzo[ c]izoksazolo-[4,5-e]azepin-4-ylo)acetamidu

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
DE3778559D1 (de) * 1986-01-21 1992-06-04 Boehringer Ingelheim Kg Thieno-1,4-diazepine.
DE3610848A1 (de) * 1986-04-01 1987-10-15 Boehringer Ingelheim Kg Neue 1,4-diazepine
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
ES2039408T3 (es) * 1986-11-17 1993-10-01 Yoshitomi Pharmaceutical Industries, Ltd. Un procedimiento para preparar un compuesto de tienotriazolodiazepina.

Also Published As

Publication number Publication date
KR890017252A (ko) 1989-12-15
DE68919378T2 (de) 1995-03-30
EP0342587B1 (en) 1994-11-17
CA1322367C (en) 1993-09-21
DE68919378D1 (de) 1994-12-22
KR910007978B1 (ko) 1991-10-05
EP0342587A2 (en) 1989-11-23
JPH0641471B2 (ja) 1994-06-01
EP0342587A3 (en) 1991-05-22
JPH0249787A (ja) 1990-02-20
US4910194A (en) 1990-03-20
ATE114154T1 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
SE8602723L (sv) Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem
ES2030409T3 (es) Procedimiento para preparar y purificar compuestos termolabiles .
BG33286A3 (bg) Метод за получаване на нови 4-хидрокси-2н-1,2 -бензотиазин-3-карбоксамид-1,1-двуориси,тяхната употреба и съдържащи тези съединения лекарствени средства
NO170280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
UA19171A (uk) Спосіб одержаhhя фіhілалкіламіhів або їх фармакологічhо прийhятhих солей
BG103219A (bg) Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие
ES2085337T3 (es) Comprimidos farmaceuticos.
ES502656A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-propanol
ATE45153T1 (de) Benzisoselenazolthione, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische produkte.
ES2095208T3 (es) Compuestos de tienotriazolodiazepina y usos farmaceuticos de los mismos.
LV10250A (lv) Jauni antiaritmijas lidzekli panemiens to iegusanai arstniecibas lidzeklis pielietojums
ES2039408T3 (es) Un procedimiento para preparar un compuesto de tienotriazolodiazepina.
DE68919378D1 (de) Thienotriazolodiazepine und ihre pharmazeutische Verwendung.
FR2524314B1 (fr) Medicament a action salidiuretique, contenant des dihydropyridines
BG50159A3 (bg) Метод за получаване на производни на пиранобензоксадиазол
IT1230115B (it) Procedimento per combattere le malattie fungine delle piante
IT8448983A0 (it) Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
ES2043696T3 (es) Derivados de prostaglandina e1 (derivados-pge1) como substancias activas farmaceuticas y medicamentos que contienen estos compuestos, especialmente para aplicacion transcutanea.
ES2058203T3 (es) Derivados del acido pirocatequincarboxilico, su obtencion y empleo como substancias activas para medicamentos.
ES8801173A1 (es) Procedimiento de producir agentes terapeuticos y profilacticos para ulceras pepticas
FR2387221A1 (fr) Derives du benzimidazole utilisables comme substances actives de medicaments veterinaires
FR2392990A1 (fr) Medicament a base d'un compose heterocyclique bicyclique condense
DK197689D0 (da) Pyridazinderivater
FR2766183B1 (fr) Medicaments contenant des polyhydroxybutylpyrazines, les polyhydroxybutylpyrazines nouvelles et leur preparation
FR2376661A1 (fr) Medicaments anthelminthiques renfermant comme substances actives des anilinomethylene-malononitriles

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 342587

Country of ref document: ES